Sign Up Today and Learn More About Mirador Therapeutics Stock
Invest in or calculate the value of your shares in Mirador Therapeutics or other pre-IPO companies through EquityZen's platform.
Mirador Therapeutics Stock
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
About Mirador Therapeutics Stock
Founded
2024
Headquarters
San Diego, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Mirador Therapeutics Press Mentions
Stay in the know about the latest news on Mirador Therapeutics
Methods, compositions, and kits for treatment of inflammatory diseases by …
patents • Feb 01, 2026
JPM Deals Recap: Boston Scientific Acquisition, a Mega Round for Parabilis, Enodia Emerges & More
medcitynews • Jan 22, 2026
Stem Cell Banking Market Projected to Reach US$ 27.95 Billion by 2035, Supported by Advancing Clinical Development Activity | Astute Analytica
globenewswire • Jan 19, 2026
The Week’s 10 Biggest Funding Rounds: A Busy Time For Robotics, Defense Tech And AI
news • Jan 16, 2026
Mirador Raises $250M in Series B Funding
finsmes • Jan 15, 2026
Mirador Therapeutics Management
Leadership team at Mirador Therapeutics
Board of Director
Kristina Burow
CFO
Gregg Gilbert
Join now and verify your accreditation status to gain access to:
- Mirador Therapeutics Current Valuation
- Mirador Therapeutics Stock Price
- Mirador Therapeutics Management
- Available deals in Mirador Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Mirador Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Mirador Therapeutics Revenue and Financials
- Mirador Therapeutics Highlights
- Mirador Therapeutics Business Model
- Mirador Therapeutics Risk Factors
- Mirador Therapeutics Research Report from SACRA Research
Trading Mirador Therapeutics Stock
How to invest in Mirador Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Mirador Therapeutics through EquityZen funds. These investments are made available by existing Mirador Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Mirador Therapeutics stock?
Shareholders can sell their Mirador Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."